Waddell & Reed Financial’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-16,983
Closed -$1.48M 470
2020
Q2
$1.48M Sell
16,983
-67,708
-80% -$5.41M ﹤0.01% 441
2020
Q1
$4.91M Buy
+84,691
New +$6.88M 0.02% 393
2015
Q3
Sell
-158,800
Closed -$4.72M 624
2015
Q2
$4.72M Hold
158,800
0.01% 521
2015
Q1
$3.5M Buy
+158,800
New +$4.03M ﹤0.01% 523
2014
Q3
Sell
-804,800
Closed -$13.7M 542
2014
Q2
$13.7M Buy
+804,800
New +$11.1M 0.02% 388

Other funds holding EXAS

Waddell & Reed Financial's EXAS Position: Q3 2020 in Review

Waddell & Reed Financial sold out of Exact Sciences (EXAS) in Q3 2020, closing a stake of 16,983 shares — an estimated $1.48M sold.

Waddell & Reed Financial first reported a position in EXAS in Q2 2014 and held it in 5 quarters. The position peaked at $13.7M in Q2 2014. 517 funds tracked by Wall St. Rank hold EXAS as of Q3 2020.

  • Waddell & Reed Financial reported no remaining Exact Sciences position as of Q3 2020 after selling out during the quarter.
  • Waddell & Reed Financial sold 16,983 Exact Sciences shares in Q3 2020, an estimated $1.48M.
  • Waddell & Reed Financial first reported a position in Exact Sciences in Q2 2014 and held it in 5 quarters.
  • Waddell & Reed Financial's Exact Sciences position peaked at $13.7M in Q2 2014.
  • 517 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2020.

Based on Waddell & Reed Financial's 13F filing for Q3 2020, filed 13 Nov 2020.